Nov 12, 2019 / 10:35PM GMT
Erin Elizabeth Wilson Wright - Crédit Suisse AG - Research Division - Director & Senior Equity Research Analyst
So hello, good afternoon, everybody. My name is Erin Wright. I cover life sciences tools, diagnostics at Credit Suisse.
We're happy to have Lantheus Holdings with us today. And with them, we have Mary Anne Heino, President and CEO; and in the audience, we also have Mark Kinarney as well, who heads up the IR effort. But I think I will hand it over to Mary Anne for a hopefully enlightening presentation.
Mary Anne Heino - Lantheus Holdings, Inc. - CEO, President & Director
Thank you, Erin. Good afternoon, everyone, and thank you for joining today.
Next slide, please. These are the statements that I am obliged to offer you today. I think it's particularly important to say because as part of my presentation today, I will speak to the transaction that we announced on October 1, our intention to acquire Progenics Pharmaceuticals. And so especially as I make comments about that today, I think the safe
Lantheus Holdings Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 13, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers